111.38 USD
-0.92
0.82%
At close Updated May 8, 4:00 PM EDT
Pre-market
After hours
111.35
-0.03
0.03%
1 day
-0.82%
5 days
-0.03%
1 month
-9.58%
3 months
-5.33%
6 months
28.39%
Year to date
4.63%
1 year
43.44%
5 years
49.32%
10 years
115.77%
 

About: Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Employees: 75,000

0
Funds holding %
of 8,139 funds
0
Analysts bullish %
of 3 analysts
0
Positive news %
of 60 articles
Price charts implemented using Lightweight Charts™